A machine learning approach for precision diagnosis of juvenile-onset SLE
Robinson, G. A.; Peng, J.; Dönnes, P.; Coelewij, L.; Radziszewska, A.; Wincup, C.; Peckham, H.; Isenberg, D. A.; Ioannou, Y.; Ciurtin, C.; Pineda-Torra, I.; Jury, E. C.
Show abstract
Juvenile-Onset systemic lupus erythematosus (JSLE) is an autoimmune rheumatic disease characterised by systemic inflammation and organ damage, with disease onset often coinciding with puberty. JSLE is associated with more severe disease manifestations and a higher motility rate compared to adult SLE. Due to the heterogeneous clinical and immunological manifestations of JSLE, delayed diagnosis and poor treatment efficacy are major barriers for improving patient outcome. In order to define a unique immunophenotyping profile distinguishing JSLE patients from age matched healthy controls, immune-based machine learning (ML) approaches were applied. Balanced random forest analysis discriminated JSLE patients from healthy controls with an overall 91% prediction accuracy. The top-ranked immunological features were selected from the optimal ML model and were validated by partial least squares discriminant analysis and logistic regression analysis. Patients could be clustered into four distinct groups based on the top hits from the ML model, providing an opportunity for tailored therapy. Moreover, complex correlations between the JSLE immune profile and clinical features of disease were identified. Further immunological association studies are essential for developing data-driven personalised medicine approaches to aid diagnosis of JSLE for targeted therapy and improved patient outcomes.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Inflammation-profiling reveals activated pathways and biomarkers with predictive potential in oligoarticular JIA 92%
- Characterization of novel TMEM173 mutation with additive IFIH1 risk allele 92%
- Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients 92%
Similar papers in this journal
- Meta-analysis of 208,370 East Asians identifies 113 genomic loci and yields new non-immune cell relevant biological insights for systemic lupus erythematosus 94%
- Clinical Outcomes of Patients with COVID-19 and Chronic Inflammatory and Autoimmune Rheumatic Diseases: A Multicentric Matched-Cohort Study 94%
- BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in Systemic Lupus Erythematosus 92%
Similar papers in this journal
- Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort Study 93%
- Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus 92%
- Clinical and Molecular Data to Predict Flares in DMARD optimization in Rheumatoid Arthritis: A Randomised, Controlled, Open-label, Non-inferiority Trial 91%
Similar papers in this journal
- Single-cell level characterization of B cell depletion and repopulation following rituximab in systemic lupus erythematosus 95%
- Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases 92%
- Identification and Evaluation of Serum Protein Biomarkers Which Differentiate Psoriatic from Rheumatoid Arthritis 91%
Similar papers in this journal
- SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Pediatric Rheumatology Database in Germany 91%
- Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe? 90%
- Genetic dissection of HLA-DRB1*15:01 and XL9 region variants in Japanese patients with systemic lupus erythematosus: Primary role for HLA-DRB1*15:01 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.